nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Sulfadiazine—malaria	0.125	0.2	CbGbCtD
Epoprostenol—CYP2C9—Pyrimethamine—malaria	0.125	0.2	CbGbCtD
Epoprostenol—CYP2C9—Artemether—malaria	0.107	0.17	CbGbCtD
Epoprostenol—CYP2C9—Proguanil—malaria	0.1	0.16	CbGbCtD
Epoprostenol—CYP2C9—Quinine—malaria	0.0646	0.103	CbGbCtD
Epoprostenol—CYP2C9—Quinidine—malaria	0.0567	0.0904	CbGbCtD
Epoprostenol—CYP2C9—Dapsone—malaria	0.0489	0.078	CbGbCtD
Epoprostenol—PTGIS—endothelium—malaria	0.019	0.16	CbGeAlD
Epoprostenol—P2RY12—blood plasma—malaria	0.0152	0.128	CbGeAlD
Epoprostenol—PTGIR—endothelium—malaria	0.0109	0.0917	CbGeAlD
Epoprostenol—PTGIR—blood plasma—malaria	0.00969	0.0815	CbGeAlD
Epoprostenol—P2RY12—hematopoietic system—malaria	0.0084	0.0706	CbGeAlD
Epoprostenol—PTGER1—kidney—malaria	0.00711	0.0598	CbGeAlD
Epoprostenol—P2RY12—blood—malaria	0.00557	0.0468	CbGeAlD
Epoprostenol—PTGIR—hematopoietic system—malaria	0.00536	0.045	CbGeAlD
Epoprostenol—PTGIS—liver—malaria	0.00484	0.0406	CbGeAlD
Epoprostenol—Dinoprost Tromethamine—HPGDS—malaria	0.00479	0.565	CrCbGaD
Epoprostenol—PTGIR—kidney—malaria	0.00439	0.0369	CbGeAlD
Epoprostenol—PTGIS—brain—malaria	0.00384	0.0322	CbGeAlD
Epoprostenol—PTGIR—digestive system—malaria	0.00373	0.0313	CbGeAlD
Epoprostenol—Dinoprostone—HPGDS—malaria	0.00368	0.435	CrCbGaD
Epoprostenol—PTGIR—blood—malaria	0.00355	0.0298	CbGeAlD
Epoprostenol—CYP2C9—blood plasma—malaria	0.00346	0.0291	CbGeAlD
Epoprostenol—P2RY12—brain—malaria	0.00345	0.029	CbGeAlD
Epoprostenol—PTGIR—liver—malaria	0.00278	0.0233	CbGeAlD
Epoprostenol—PTGIR—brain—malaria	0.0022	0.0185	CbGeAlD
Epoprostenol—CYP2C9—hematopoietic system—malaria	0.00192	0.0161	CbGeAlD
Epoprostenol—CYP2C9—digestive system—malaria	0.00133	0.0112	CbGeAlD
Epoprostenol—CYP2C9—blood—malaria	0.00127	0.0107	CbGeAlD
Epoprostenol—CYP2C9—liver—malaria	0.000992	0.00834	CbGeAlD
Epoprostenol—Infestation—Pentoxifylline—malaria	0.000851	0.00349	CcSEcCtD
Epoprostenol—Diarrhoea—Proguanil—malaria	0.00085	0.00349	CcSEcCtD
Epoprostenol—Haemorrhage—Quinine—malaria	0.000848	0.00348	CcSEcCtD
Epoprostenol—Haemorrhage—Quinidine—malaria	0.000848	0.00348	CcSEcCtD
Epoprostenol—Anaphylactic shock—Sulfadiazine—malaria	0.000825	0.00338	CcSEcCtD
Epoprostenol—Sweating—Quinidine barbiturate—malaria	0.000817	0.00335	CcSEcCtD
Epoprostenol—Sweating—Pentoxifylline—malaria	0.000816	0.00335	CcSEcCtD
Epoprostenol—Thrombocytopenia—Sulfadiazine—malaria	0.000808	0.00331	CcSEcCtD
Epoprostenol—Epistaxis—Pentoxifylline—malaria	0.000803	0.00329	CcSEcCtD
Epoprostenol—Flushing—Clindamycin—malaria	0.000802	0.00329	CcSEcCtD
Epoprostenol—Vomiting—Proguanil—malaria	0.00079	0.00324	CcSEcCtD
Epoprostenol—Flushing—Quinine—malaria	0.000787	0.00323	CcSEcCtD
Epoprostenol—Cardiac disorder—Quinidine—malaria	0.000787	0.00323	CcSEcCtD
Epoprostenol—Cardiac disorder—Quinine—malaria	0.000787	0.00323	CcSEcCtD
Epoprostenol—Flushing—Quinidine—malaria	0.000787	0.00323	CcSEcCtD
Epoprostenol—Anorexia—Sulfadiazine—malaria	0.000786	0.00323	CcSEcCtD
Epoprostenol—Rash—Proguanil—malaria	0.000783	0.00321	CcSEcCtD
Epoprostenol—Dermatitis—Proguanil—malaria	0.000783	0.00321	CcSEcCtD
Epoprostenol—Bradycardia—Quinidine barbiturate—malaria	0.000779	0.0032	CcSEcCtD
Epoprostenol—Headache—Proguanil—malaria	0.000778	0.00319	CcSEcCtD
Epoprostenol—Haemoglobin—Quinidine barbiturate—malaria	0.000769	0.00316	CcSEcCtD
Epoprostenol—Haemoglobin—Pentoxifylline—malaria	0.000768	0.00315	CcSEcCtD
Epoprostenol—Haemorrhage—Quinidine barbiturate—malaria	0.000765	0.00314	CcSEcCtD
Epoprostenol—Mediastinal disorder—Quinine—malaria	0.000764	0.00314	CcSEcCtD
Epoprostenol—Mediastinal disorder—Quinidine—malaria	0.000764	0.00314	CcSEcCtD
Epoprostenol—Haemorrhage—Pentoxifylline—malaria	0.000764	0.00313	CcSEcCtD
Epoprostenol—Chills—Quinidine—malaria	0.000761	0.00312	CcSEcCtD
Epoprostenol—Chills—Quinine—malaria	0.000761	0.00312	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000751	0.00308	CcSEcCtD
Epoprostenol—Insomnia—Sulfadiazine—malaria	0.000746	0.00306	CcSEcCtD
Epoprostenol—Mental disorder—Quinidine—malaria	0.000743	0.00305	CcSEcCtD
Epoprostenol—Mental disorder—Quinine—malaria	0.000743	0.00305	CcSEcCtD
Epoprostenol—Flatulence—Clindamycin—malaria	0.000742	0.00304	CcSEcCtD
Epoprostenol—Nausea—Proguanil—malaria	0.000738	0.00303	CcSEcCtD
Epoprostenol—Back pain—Clindamycin—malaria	0.000728	0.00299	CcSEcCtD
Epoprostenol—Muscle spasms—Clindamycin—malaria	0.000724	0.00297	CcSEcCtD
Epoprostenol—Decreased appetite—Sulfadiazine—malaria	0.000717	0.00294	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Sulfadiazine—malaria	0.000712	0.00292	CcSEcCtD
Epoprostenol—Cardiac disorder—Quinidine barbiturate—malaria	0.00071	0.00291	CcSEcCtD
Epoprostenol—Flushing—Quinidine barbiturate—malaria	0.00071	0.00291	CcSEcCtD
Epoprostenol—Flushing—Pentoxifylline—malaria	0.000709	0.00291	CcSEcCtD
Epoprostenol—Anaemia—Clindamycin—malaria	0.000696	0.00285	CcSEcCtD
Epoprostenol—Tremor—Quinine—malaria	0.000692	0.00284	CcSEcCtD
Epoprostenol—Tremor—Quinidine—malaria	0.000692	0.00284	CcSEcCtD
Epoprostenol—Mediastinal disorder—Quinidine barbiturate—malaria	0.00069	0.00283	CcSEcCtD
Epoprostenol—Chills—Quinidine barbiturate—malaria	0.000687	0.00282	CcSEcCtD
Epoprostenol—Cough—Dapsone—malaria	0.000679	0.00278	CcSEcCtD
Epoprostenol—Agitation—Quinine—malaria	0.000678	0.00278	CcSEcCtD
Epoprostenol—Agitation—Quinidine—malaria	0.000678	0.00278	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Sulfadiazine—malaria	0.000674	0.00277	CcSEcCtD
Epoprostenol—Mental disorder—Quinidine barbiturate—malaria	0.000671	0.00275	CcSEcCtD
Epoprostenol—Syncope—Quinine—malaria	0.000662	0.00272	CcSEcCtD
Epoprostenol—Syncope—Quinidine—malaria	0.000662	0.00272	CcSEcCtD
Epoprostenol—Flatulence—Pentoxifylline—malaria	0.000655	0.00269	CcSEcCtD
Epoprostenol—Urticaria—Sulfadiazine—malaria	0.000655	0.00269	CcSEcCtD
Epoprostenol—Tension—Quinidine barbiturate—malaria	0.000654	0.00268	CcSEcCtD
Epoprostenol—Tension—Pentoxifylline—malaria	0.000653	0.00268	CcSEcCtD
Epoprostenol—Palpitations—Quinine—malaria	0.000652	0.00268	CcSEcCtD
Epoprostenol—Palpitations—Quinidine—malaria	0.000652	0.00268	CcSEcCtD
Epoprostenol—Abdominal pain—Sulfadiazine—malaria	0.000652	0.00267	CcSEcCtD
Epoprostenol—Body temperature increased—Sulfadiazine—malaria	0.000652	0.00267	CcSEcCtD
Epoprostenol—Loss of consciousness—Quinine—malaria	0.000649	0.00266	CcSEcCtD
Epoprostenol—Loss of consciousness—Quinidine—malaria	0.000649	0.00266	CcSEcCtD
Epoprostenol—Nervousness—Quinidine barbiturate—malaria	0.000647	0.00265	CcSEcCtD
Epoprostenol—Nervousness—Pentoxifylline—malaria	0.000646	0.00265	CcSEcCtD
Epoprostenol—Back pain—Pentoxifylline—malaria	0.000643	0.00264	CcSEcCtD
Epoprostenol—Muscle spasms—Pentoxifylline—malaria	0.000639	0.00262	CcSEcCtD
Epoprostenol—Myalgia—Quinidine—malaria	0.000629	0.00258	CcSEcCtD
Epoprostenol—Chest pain—Quinine—malaria	0.000629	0.00258	CcSEcCtD
Epoprostenol—Chest pain—Quinidine—malaria	0.000629	0.00258	CcSEcCtD
Epoprostenol—Myalgia—Quinine—malaria	0.000629	0.00258	CcSEcCtD
Epoprostenol—Tremor—Quinidine barbiturate—malaria	0.000624	0.00256	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000624	0.00256	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000624	0.00256	CcSEcCtD
Epoprostenol—Tremor—Pentoxifylline—malaria	0.000623	0.00256	CcSEcCtD
Epoprostenol—Tachycardia—Dapsone—malaria	0.00062	0.00254	CcSEcCtD
Epoprostenol—Anaemia—Pentoxifylline—malaria	0.000615	0.00252	CcSEcCtD
Epoprostenol—Anaphylactic shock—Clindamycin—malaria	0.000614	0.00252	CcSEcCtD
Epoprostenol—Agitation—Quinidine barbiturate—malaria	0.000612	0.00251	CcSEcCtD
Epoprostenol—Agitation—Pentoxifylline—malaria	0.000611	0.00251	CcSEcCtD
Epoprostenol—Hypersensitivity—Sulfadiazine—malaria	0.000608	0.00249	CcSEcCtD
Epoprostenol—Confusional state—Quinidine—malaria	0.000608	0.00249	CcSEcCtD
Epoprostenol—Confusional state—Quinine—malaria	0.000608	0.00249	CcSEcCtD
Epoprostenol—Oedema—Quinine—malaria	0.000603	0.00247	CcSEcCtD
Epoprostenol—Oedema—Quinidine—malaria	0.000603	0.00247	CcSEcCtD
Epoprostenol—Thrombocytopenia—Clindamycin—malaria	0.000601	0.00247	CcSEcCtD
Epoprostenol—Syncope—Quinidine barbiturate—malaria	0.000598	0.00245	CcSEcCtD
Epoprostenol—Shock—Quinidine—malaria	0.000593	0.00243	CcSEcCtD
Epoprostenol—Shock—Quinine—malaria	0.000593	0.00243	CcSEcCtD
Epoprostenol—Nervous system disorder—Quinidine—malaria	0.000591	0.00242	CcSEcCtD
Epoprostenol—Nervous system disorder—Quinine—malaria	0.000591	0.00242	CcSEcCtD
Epoprostenol—Thrombocytopenia—Quinidine—malaria	0.00059	0.00242	CcSEcCtD
Epoprostenol—Thrombocytopenia—Quinine—malaria	0.00059	0.00242	CcSEcCtD
Epoprostenol—Palpitations—Quinidine barbiturate—malaria	0.000589	0.00242	CcSEcCtD
Epoprostenol—Tachycardia—Quinine—malaria	0.000588	0.00241	CcSEcCtD
Epoprostenol—Tachycardia—Quinidine—malaria	0.000588	0.00241	CcSEcCtD
Epoprostenol—Palpitations—Pentoxifylline—malaria	0.000588	0.00241	CcSEcCtD
Epoprostenol—Loss of consciousness—Quinidine barbiturate—malaria	0.000586	0.0024	CcSEcCtD
Epoprostenol—Skin disorder—Quinidine—malaria	0.000585	0.0024	CcSEcCtD
Epoprostenol—Skin disorder—Quinine—malaria	0.000585	0.0024	CcSEcCtD
Epoprostenol—Pruritus—Sulfadiazine—malaria	0.000584	0.00239	CcSEcCtD
Epoprostenol—Hyperhidrosis—Quinidine—malaria	0.000583	0.00239	CcSEcCtD
Epoprostenol—Hyperhidrosis—Quinine—malaria	0.000583	0.00239	CcSEcCtD
Epoprostenol—Anorexia—Quinine—malaria	0.000574	0.00236	CcSEcCtD
Epoprostenol—Anorexia—Quinidine—malaria	0.000574	0.00236	CcSEcCtD
Epoprostenol—Insomnia—Dapsone—malaria	0.000574	0.00236	CcSEcCtD
Epoprostenol—Hypotension—Clindamycin—malaria	0.000574	0.00235	CcSEcCtD
Epoprostenol—Arthralgia—Quinidine barbiturate—malaria	0.000567	0.00233	CcSEcCtD
Epoprostenol—Chest pain—Quinidine barbiturate—malaria	0.000567	0.00233	CcSEcCtD
Epoprostenol—Myalgia—Quinidine barbiturate—malaria	0.000567	0.00233	CcSEcCtD
Epoprostenol—Chest pain—Pentoxifylline—malaria	0.000566	0.00232	CcSEcCtD
Epoprostenol—Myalgia—Pentoxifylline—malaria	0.000566	0.00232	CcSEcCtD
Epoprostenol—Anxiety—Quinidine barbiturate—malaria	0.000565	0.00232	CcSEcCtD
Epoprostenol—Diarrhoea—Sulfadiazine—malaria	0.000564	0.00231	CcSEcCtD
Epoprostenol—Anxiety—Pentoxifylline—malaria	0.000564	0.00231	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000563	0.00231	CcSEcCtD
Epoprostenol—Hypotension—Quinine—malaria	0.000563	0.00231	CcSEcCtD
Epoprostenol—Hypotension—Quinidine—malaria	0.000563	0.00231	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000562	0.00231	CcSEcCtD
Epoprostenol—Dry mouth—Pentoxifylline—malaria	0.000554	0.00227	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Quinine—malaria	0.000549	0.00225	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Quinidine—malaria	0.000549	0.00225	CcSEcCtD
Epoprostenol—Confusional state—Quinidine barbiturate—malaria	0.000548	0.00225	CcSEcCtD
Epoprostenol—Dyspnoea—Clindamycin—malaria	0.000548	0.00225	CcSEcCtD
Epoprostenol—Confusional state—Pentoxifylline—malaria	0.000547	0.00225	CcSEcCtD
Epoprostenol—Oedema—Quinidine barbiturate—malaria	0.000544	0.00223	CcSEcCtD
Epoprostenol—Anaphylactic shock—Pentoxifylline—malaria	0.000543	0.00223	CcSEcCtD
Epoprostenol—Oedema—Pentoxifylline—malaria	0.000543	0.00223	CcSEcCtD
Epoprostenol—Dyspepsia—Clindamycin—malaria	0.000541	0.00222	CcSEcCtD
Epoprostenol—Infection—Pentoxifylline—malaria	0.000539	0.00221	CcSEcCtD
Epoprostenol—Dyspnoea—Quinidine—malaria	0.000537	0.0022	CcSEcCtD
Epoprostenol—Dyspnoea—Quinine—malaria	0.000537	0.0022	CcSEcCtD
Epoprostenol—Shock—Quinidine barbiturate—malaria	0.000535	0.00219	CcSEcCtD
Epoprostenol—Shock—Pentoxifylline—malaria	0.000534	0.00219	CcSEcCtD
Epoprostenol—Nervous system disorder—Quinidine barbiturate—malaria	0.000533	0.00219	CcSEcCtD
Epoprostenol—Thrombocytopenia—Quinidine barbiturate—malaria	0.000532	0.00218	CcSEcCtD
Epoprostenol—Thrombocytopenia—Pentoxifylline—malaria	0.000531	0.00218	CcSEcCtD
Epoprostenol—Tachycardia—Quinidine barbiturate—malaria	0.000531	0.00218	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Clindamycin—malaria	0.00053	0.00218	CcSEcCtD
Epoprostenol—Tachycardia—Pentoxifylline—malaria	0.00053	0.00217	CcSEcCtD
Epoprostenol—Fatigue—Clindamycin—malaria	0.00053	0.00217	CcSEcCtD
Epoprostenol—Skin disorder—Quinidine barbiturate—malaria	0.000528	0.00217	CcSEcCtD
Epoprostenol—Skin disorder—Pentoxifylline—malaria	0.000527	0.00216	CcSEcCtD
Epoprostenol—Hyperhidrosis—Quinidine barbiturate—malaria	0.000526	0.00216	CcSEcCtD
Epoprostenol—Pain—Clindamycin—malaria	0.000525	0.00215	CcSEcCtD
Epoprostenol—Constipation—Clindamycin—malaria	0.000525	0.00215	CcSEcCtD
Epoprostenol—Hyperhidrosis—Pentoxifylline—malaria	0.000525	0.00215	CcSEcCtD
Epoprostenol—Vomiting—Sulfadiazine—malaria	0.000524	0.00215	CcSEcCtD
Epoprostenol—Decreased appetite—Quinine—malaria	0.000524	0.00215	CcSEcCtD
Epoprostenol—Decreased appetite—Quinidine—malaria	0.000524	0.00215	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Quinine—malaria	0.00052	0.00213	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Quinidine—malaria	0.00052	0.00213	CcSEcCtD
Epoprostenol—Rash—Sulfadiazine—malaria	0.00052	0.00213	CcSEcCtD
Epoprostenol—Dermatitis—Sulfadiazine—malaria	0.00052	0.00213	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Dapsone—malaria	0.000519	0.00213	CcSEcCtD
Epoprostenol—Anorexia—Quinidine barbiturate—malaria	0.000518	0.00213	CcSEcCtD
Epoprostenol—Anorexia—Pentoxifylline—malaria	0.000517	0.00212	CcSEcCtD
Epoprostenol—Headache—Sulfadiazine—malaria	0.000517	0.00212	CcSEcCtD
Epoprostenol—Hypotension—Quinidine barbiturate—malaria	0.000508	0.00208	CcSEcCtD
Epoprostenol—Hypotension—Pentoxifylline—malaria	0.000507	0.00208	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Clindamycin—malaria	0.000502	0.00206	CcSEcCtD
Epoprostenol—Abdominal pain—Dapsone—malaria	0.000502	0.00206	CcSEcCtD
Epoprostenol—Body temperature increased—Dapsone—malaria	0.000502	0.00206	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000495	0.00203	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000495	0.00203	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Quinine—malaria	0.000493	0.00202	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Quinidine—malaria	0.000493	0.00202	CcSEcCtD
Epoprostenol—Insomnia—Pentoxifylline—malaria	0.000491	0.00201	CcSEcCtD
Epoprostenol—Nausea—Sulfadiazine—malaria	0.00049	0.00201	CcSEcCtD
Epoprostenol—Urticaria—Clindamycin—malaria	0.000488	0.002	CcSEcCtD
Epoprostenol—Abdominal pain—Clindamycin—malaria	0.000486	0.00199	CcSEcCtD
Epoprostenol—Body temperature increased—Clindamycin—malaria	0.000486	0.00199	CcSEcCtD
Epoprostenol—Dyspnoea—Quinidine barbiturate—malaria	0.000485	0.00199	CcSEcCtD
Epoprostenol—Dyspnoea—Pentoxifylline—malaria	0.000484	0.00199	CcSEcCtD
Epoprostenol—Somnolence—Quinidine barbiturate—malaria	0.000483	0.00198	CcSEcCtD
Epoprostenol—Somnolence—Pentoxifylline—malaria	0.000483	0.00198	CcSEcCtD
Epoprostenol—Urticaria—Quinine—malaria	0.000479	0.00196	CcSEcCtD
Epoprostenol—Urticaria—Quinidine—malaria	0.000479	0.00196	CcSEcCtD
Epoprostenol—Dyspepsia—Pentoxifylline—malaria	0.000478	0.00196	CcSEcCtD
Epoprostenol—Body temperature increased—Quinidine—malaria	0.000476	0.00195	CcSEcCtD
Epoprostenol—Abdominal pain—Quinine—malaria	0.000476	0.00195	CcSEcCtD
Epoprostenol—Abdominal pain—Quinidine—malaria	0.000476	0.00195	CcSEcCtD
Epoprostenol—Body temperature increased—Quinine—malaria	0.000476	0.00195	CcSEcCtD
Epoprostenol—Decreased appetite—Quinidine barbiturate—malaria	0.000473	0.00194	CcSEcCtD
Epoprostenol—Decreased appetite—Pentoxifylline—malaria	0.000472	0.00194	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000469	0.00193	CcSEcCtD
Epoprostenol—Pain—Quinidine barbiturate—malaria	0.000465	0.00191	CcSEcCtD
Epoprostenol—Constipation—Quinidine barbiturate—malaria	0.000465	0.00191	CcSEcCtD
Epoprostenol—Constipation—Pentoxifylline—malaria	0.000464	0.0019	CcSEcCtD
Epoprostenol—Hypersensitivity—Clindamycin—malaria	0.000453	0.00186	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000445	0.00182	CcSEcCtD
Epoprostenol—Hypersensitivity—Quinidine—malaria	0.000444	0.00182	CcSEcCtD
Epoprostenol—Hypersensitivity—Quinine—malaria	0.000444	0.00182	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Pentoxifylline—malaria	0.000444	0.00182	CcSEcCtD
Epoprostenol—Asthenia—Clindamycin—malaria	0.000441	0.00181	CcSEcCtD
Epoprostenol—Pruritus—Clindamycin—malaria	0.000435	0.00178	CcSEcCtD
Epoprostenol—Asthenia—Quinidine—malaria	0.000432	0.00177	CcSEcCtD
Epoprostenol—Asthenia—Quinine—malaria	0.000432	0.00177	CcSEcCtD
Epoprostenol—Urticaria—Quinidine barbiturate—malaria	0.000432	0.00177	CcSEcCtD
Epoprostenol—Urticaria—Pentoxifylline—malaria	0.000431	0.00177	CcSEcCtD
Epoprostenol—Body temperature increased—Quinidine barbiturate—malaria	0.00043	0.00176	CcSEcCtD
Epoprostenol—Abdominal pain—Quinidine barbiturate—malaria	0.00043	0.00176	CcSEcCtD
Epoprostenol—Body temperature increased—Pentoxifylline—malaria	0.000429	0.00176	CcSEcCtD
Epoprostenol—Abdominal pain—Pentoxifylline—malaria	0.000429	0.00176	CcSEcCtD
Epoprostenol—Pruritus—Quinidine—malaria	0.000426	0.00175	CcSEcCtD
Epoprostenol—Pruritus—Quinine—malaria	0.000426	0.00175	CcSEcCtD
Epoprostenol—Diarrhoea—Clindamycin—malaria	0.00042	0.00172	CcSEcCtD
Epoprostenol—Diarrhoea—Quinidine—malaria	0.000412	0.00169	CcSEcCtD
Epoprostenol—Diarrhoea—Quinine—malaria	0.000412	0.00169	CcSEcCtD
Epoprostenol—Dizziness—Clindamycin—malaria	0.000406	0.00167	CcSEcCtD
Epoprostenol—Vomiting—Dapsone—malaria	0.000404	0.00166	CcSEcCtD
Epoprostenol—Hypersensitivity—Quinidine barbiturate—malaria	0.000401	0.00164	CcSEcCtD
Epoprostenol—Hypersensitivity—Pentoxifylline—malaria	0.0004	0.00164	CcSEcCtD
Epoprostenol—Dizziness—Quinidine—malaria	0.000398	0.00163	CcSEcCtD
Epoprostenol—Dizziness—Quinine—malaria	0.000398	0.00163	CcSEcCtD
Epoprostenol—Headache—Dapsone—malaria	0.000398	0.00163	CcSEcCtD
Epoprostenol—Vomiting—Clindamycin—malaria	0.000391	0.0016	CcSEcCtD
Epoprostenol—Asthenia—Quinidine barbiturate—malaria	0.00039	0.0016	CcSEcCtD
Epoprostenol—Asthenia—Pentoxifylline—malaria	0.000389	0.0016	CcSEcCtD
Epoprostenol—Rash—Clindamycin—malaria	0.000387	0.00159	CcSEcCtD
Epoprostenol—Dermatitis—Clindamycin—malaria	0.000387	0.00159	CcSEcCtD
Epoprostenol—Headache—Clindamycin—malaria	0.000385	0.00158	CcSEcCtD
Epoprostenol—Pruritus—Quinidine barbiturate—malaria	0.000385	0.00158	CcSEcCtD
Epoprostenol—Pruritus—Pentoxifylline—malaria	0.000384	0.00158	CcSEcCtD
Epoprostenol—Vomiting—Quinidine—malaria	0.000383	0.00157	CcSEcCtD
Epoprostenol—Vomiting—Quinine—malaria	0.000383	0.00157	CcSEcCtD
Epoprostenol—Rash—Quinidine—malaria	0.00038	0.00156	CcSEcCtD
Epoprostenol—Rash—Quinine—malaria	0.00038	0.00156	CcSEcCtD
Epoprostenol—Dermatitis—Quinine—malaria	0.00038	0.00156	CcSEcCtD
Epoprostenol—Dermatitis—Quinidine—malaria	0.00038	0.00156	CcSEcCtD
Epoprostenol—Headache—Quinine—malaria	0.000377	0.00155	CcSEcCtD
Epoprostenol—Headache—Quinidine—malaria	0.000377	0.00155	CcSEcCtD
Epoprostenol—Nausea—Dapsone—malaria	0.000377	0.00155	CcSEcCtD
Epoprostenol—Diarrhoea—Quinidine barbiturate—malaria	0.000372	0.00153	CcSEcCtD
Epoprostenol—Diarrhoea—Pentoxifylline—malaria	0.000371	0.00152	CcSEcCtD
Epoprostenol—Nausea—Clindamycin—malaria	0.000365	0.0015	CcSEcCtD
Epoprostenol—Dizziness—Quinidine barbiturate—malaria	0.00036	0.00148	CcSEcCtD
Epoprostenol—Dizziness—Pentoxifylline—malaria	0.000359	0.00147	CcSEcCtD
Epoprostenol—Nausea—Quinine—malaria	0.000358	0.00147	CcSEcCtD
Epoprostenol—Nausea—Quinidine—malaria	0.000358	0.00147	CcSEcCtD
Epoprostenol—Vomiting—Quinidine barbiturate—malaria	0.000346	0.00142	CcSEcCtD
Epoprostenol—Vomiting—Pentoxifylline—malaria	0.000345	0.00142	CcSEcCtD
Epoprostenol—Rash—Quinidine barbiturate—malaria	0.000343	0.00141	CcSEcCtD
Epoprostenol—Dermatitis—Quinidine barbiturate—malaria	0.000343	0.00141	CcSEcCtD
Epoprostenol—Rash—Pentoxifylline—malaria	0.000342	0.0014	CcSEcCtD
Epoprostenol—Dermatitis—Pentoxifylline—malaria	0.000342	0.0014	CcSEcCtD
Epoprostenol—Headache—Quinidine barbiturate—malaria	0.000341	0.0014	CcSEcCtD
Epoprostenol—Headache—Pentoxifylline—malaria	0.00034	0.00139	CcSEcCtD
Epoprostenol—Nausea—Quinidine barbiturate—malaria	0.000323	0.00133	CcSEcCtD
Epoprostenol—Nausea—Pentoxifylline—malaria	0.000322	0.00132	CcSEcCtD
Epoprostenol—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000243	0.242	CbGpPWpGaD
Epoprostenol—PTGIS—Arachidonic acid metabolism—HPGDS—malaria	8.79e-05	0.0874	CbGpPWpGaD
Epoprostenol—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	5.24e-05	0.0521	CbGpPWpGaD
Epoprostenol—PTGIS—Biological oxidations—HPGDS—malaria	3.27e-05	0.0325	CbGpPWpGaD
Epoprostenol—PTGIR—Thromboxane A2 receptor signaling—ICAM1—malaria	2.81e-05	0.0279	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	2.5e-05	0.0249	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	2.3e-05	0.0229	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	2.3e-05	0.0229	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—DECR1—malaria	2.29e-05	0.0228	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—FAS—malaria	2.27e-05	0.0225	CbGpPWpGaD
Epoprostenol—PTGIR—Platelet homeostasis—NOS2—malaria	2.13e-05	0.0212	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—ACKR1—malaria	1.9e-05	0.0189	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—HBB—malaria	1.81e-05	0.018	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—ACKR1—malaria	1.75e-05	0.0174	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—ACKR1—malaria	1.75e-05	0.0174	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—HBB—malaria	1.67e-05	0.0166	CbGpPWpGaD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	1.42e-05	0.0141	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—DHODH—malaria	1.28e-05	0.0127	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.26e-05	0.0125	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—CD36—malaria	1.23e-05	0.0122	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.15e-05	0.0115	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—SLC4A1—malaria	1.09e-05	0.0108	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—DECR1—malaria	1.02e-05	0.0102	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PKLR—malaria	9.83e-06	0.00977	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—ACKR1—malaria	9.77e-06	0.00972	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—TNF—malaria	9.62e-06	0.00957	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—HBB—malaria	9.23e-06	0.00918	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—ACKR1—malaria	8.99e-06	0.00895	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—ACKR1—malaria	8.99e-06	0.00895	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—G6PD—malaria	8.76e-06	0.00871	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PKLR—malaria	8.23e-06	0.00819	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—IL6—malaria	7.77e-06	0.00772	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—G6PD—malaria	7.34e-06	0.0073	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—CD36—malaria	7.24e-06	0.0072	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IL2—malaria	6.87e-06	0.00684	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—CD36—malaria	6.32e-06	0.00629	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—DHFR—malaria	6.2e-06	0.00616	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—CD36—malaria	5.82e-06	0.00579	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ACKR1—malaria	5.77e-06	0.00574	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—HPGDS—malaria	5.59e-06	0.00556	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ACKR1—malaria	5.31e-06	0.00528	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ACKR1—malaria	5.31e-06	0.00528	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—HPGDS—malaria	5.29e-06	0.00526	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—NOS2—malaria	5.2e-06	0.00517	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—DHFR—malaria	5.19e-06	0.00516	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—SCARB1—malaria	5.14e-06	0.00511	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—NOS2—malaria	4.78e-06	0.00476	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TLR9—malaria	4.65e-06	0.00463	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TLR9—malaria	4.28e-06	0.00426	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TLR9—malaria	4.28e-06	0.00426	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	3.8e-06	0.00378	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	3.7e-06	0.00368	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IL2—malaria	3.54e-06	0.00352	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL2—malaria	3.26e-06	0.00324	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CD36—malaria	3.22e-06	0.00321	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS2—malaria	3.16e-06	0.00315	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD4—malaria	2.34e-06	0.00233	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—malaria	2.24e-06	0.00223	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DHODH—malaria	2.06e-06	0.00205	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—malaria	2.06e-06	0.00205	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—malaria	2.06e-06	0.00205	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—malaria	2.03e-06	0.00202	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.03e-06	0.00202	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—malaria	1.87e-06	0.00186	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—malaria	1.87e-06	0.00186	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.86e-06	0.00185	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—KDR—malaria	1.85e-06	0.00184	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC4A1—malaria	1.75e-06	0.00175	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KDR—malaria	1.7e-06	0.0017	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—KDR—malaria	1.7e-06	0.0017	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DECR1—malaria	1.65e-06	0.00164	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HBB—malaria	1.49e-06	0.00148	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PKLR—malaria	1.33e-06	0.00132	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—malaria	1.27e-06	0.00126	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—malaria	1.2e-06	0.00119	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—malaria	1.19e-06	0.00119	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—G6PD—malaria	1.19e-06	0.00118	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.17e-06	0.00116	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—malaria	1.11e-06	0.0011	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—malaria	1.11e-06	0.0011	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—malaria	1.1e-06	0.00109	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—malaria	1.1e-06	0.00109	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HPGDS—malaria	9.04e-07	0.000899	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DHFR—malaria	8.39e-07	0.000834	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SCARB1—malaria	8.3e-07	0.000825	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—malaria	7.06e-07	0.000702	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—malaria	6.5e-07	0.000646	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—malaria	6.5e-07	0.000646	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CD36—malaria	5.21e-07	0.000518	CbGpPWpGaD
